HK1112240A1 - 1-(2h)-isoquinolone derivative 1-(2h)- - Google Patents
1-(2h)-isoquinolone derivative 1-(2h)-Info
- Publication number
- HK1112240A1 HK1112240A1 HK08107586.7A HK08107586A HK1112240A1 HK 1112240 A1 HK1112240 A1 HK 1112240A1 HK 08107586 A HK08107586 A HK 08107586A HK 1112240 A1 HK1112240 A1 HK 1112240A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- isoquinolone derivative
- isoquinolone
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2005045926 | 2005-02-22 | ||
JP2005236919 | 2005-08-17 | ||
PCT/JP2006/303180 WO2006090743A1 (ja) | 2005-02-22 | 2006-02-22 | 1-(2h)-イソキノロン誘導体 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1112240A1 true HK1112240A1 (en) | 2008-08-29 |
Family
ID=36927381
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK08107586.7A HK1112240A1 (en) | 2005-02-22 | 2008-07-10 | 1-(2h)-isoquinolone derivative 1-(2h)- |
Country Status (11)
Country | Link |
---|---|
US (1) | US7820693B2 (zh) |
EP (1) | EP1854792B1 (zh) |
JP (1) | JP5037333B2 (zh) |
KR (1) | KR20070107139A (zh) |
CN (1) | CN101160303B (zh) |
AR (1) | AR053140A1 (zh) |
AU (1) | AU2006216289B2 (zh) |
CA (1) | CA2598330A1 (zh) |
HK (1) | HK1112240A1 (zh) |
TW (1) | TWI389897B (zh) |
WO (1) | WO2006090743A1 (zh) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1964979B (zh) | 2004-04-09 | 2011-07-27 | 中外制药株式会社 | 新颖的水溶性前药 |
GB0409877D0 (en) | 2004-04-30 | 2004-06-09 | Univ Manchester | Preparation of nanoparticle materials |
GB2429838B (en) | 2005-08-12 | 2011-03-09 | Nanoco Technologies Ltd | Nanoparticles |
TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
EP1938823A1 (en) * | 2005-10-19 | 2008-07-02 | Chugai Seiyaku Kabushiki Kaisha | Agent for preventing or treating pancreas cancer, ovary cancer or liver cancer containing novel water-soluble prodrug |
JP5250967B2 (ja) * | 2005-11-30 | 2013-07-31 | 三菱化学株式会社 | 有機化合物、電荷輸送材料、電荷輸送材料用組成物および有機電界発光素子 |
US8563348B2 (en) | 2007-04-18 | 2013-10-22 | Nanoco Technologies Ltd. | Fabrication of electrically active films based on multiple layers |
US20080264479A1 (en) | 2007-04-25 | 2008-10-30 | Nanoco Technologies Limited | Hybrid Photovoltaic Cells and Related Methods |
US8784701B2 (en) | 2007-11-30 | 2014-07-22 | Nanoco Technologies Ltd. | Preparation of nanoparticle material |
JP5749495B2 (ja) | 2008-02-25 | 2015-07-15 | ナノコ テクノロジーズ リミテッド | 半導体ナノ粒子キャッピング剤 |
GB0813273D0 (en) | 2008-07-19 | 2008-08-27 | Nanoco Technologies Ltd | Method for producing aqueous compatible nanoparticles |
GB0814458D0 (en) | 2008-08-07 | 2008-09-10 | Nanoco Technologies Ltd | Surface functionalised nanoparticles |
GB0820101D0 (en) | 2008-11-04 | 2008-12-10 | Nanoco Technologies Ltd | Surface functionalised nanoparticles |
GB0821122D0 (en) | 2008-11-19 | 2008-12-24 | Nanoco Technologies Ltd | Semiconductor nanoparticle - based light emitting devices and associated materials and methods |
WO2010061908A1 (ja) | 2008-11-28 | 2010-06-03 | 中外製薬株式会社 | 1-(2h)-イソキノロン誘導体 |
CN102348696B (zh) * | 2009-03-13 | 2015-06-17 | 太阳化学有限公司 | 可用于可能量固化的组合物中的环状氨基甲酸酯化合物 |
GB0916699D0 (en) | 2009-09-23 | 2009-11-04 | Nanoco Technologies Ltd | Semiconductor nanoparticle-based materials |
GB0916700D0 (en) | 2009-09-23 | 2009-11-04 | Nanoco Technologies Ltd | Semiconductor nanoparticle-based materials |
FR2956816B1 (fr) | 2010-03-01 | 2012-05-18 | Univ Joseph Fourier | Utilisation de quinolones pour la preparation de medicaments, nouvelles quinolones et leur procede de synthese |
GB201005601D0 (en) | 2010-04-01 | 2010-05-19 | Nanoco Technologies Ltd | Ecapsulated nanoparticles |
CN104302358B (zh) | 2012-03-07 | 2017-12-05 | 癌症研究协会:皇家癌症医院 | 3‑芳基‑5‑取代的异喹啉‑1‑酮化合物和它们的治疗用途 |
CN103965095A (zh) * | 2013-02-04 | 2014-08-06 | 艾琪康医药科技(上海)有限公司 | 1-r1-3-r2-4-氟哌啶及其衍生物的制备方法 |
AU2014320149A1 (en) | 2013-09-11 | 2016-04-07 | Institute Of Cancer Research: Royal Cancer Hospital (The) | 3-aryl-5-substituted-isoquinolin-1-one compounds and their therapeutic use |
TW201623286A (zh) | 2014-04-04 | 2016-07-01 | 賽諾菲公司 | 作為gpr119調控劑用於治療糖尿病、肥胖、血脂異常及相關病症之異吲哚啉酮化合物 |
WO2018108780A1 (en) | 2016-12-12 | 2018-06-21 | Bracco Imaging Spa | Dimeric contrast agents |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4340606A (en) | 1980-10-23 | 1982-07-20 | E. I. Du Pont De Nemours And Company | 3-(p-Alkylsulfonylphenyl)oxazolidinone derivatives as antibacterial agents |
US4461773A (en) * | 1982-09-15 | 1984-07-24 | E. I. Dupont De Nemours And Company | P-Oxooxazolidinylbenzene compounds as antibacterial agents |
US4942163A (en) * | 1989-03-07 | 1990-07-17 | E. I. Du Pont De Nemours And Company | 1(2H)-isoquinolinones and 1-isoquinolineamines as cancer chemotherapeutic agents |
NZ501650A (en) | 1997-05-13 | 2001-11-30 | Octamer Inc | Use of a pADPRT inhibitory compound that is not 3-aminobenzamide to treat inflammation and inflammatory diseases in mammals |
US20020022636A1 (en) | 1997-09-03 | 2002-02-21 | Jia-He Li | Oxo-substituted compounds, process of making, and compositions and methods for inhibiting parp activity |
US7256207B2 (en) | 2003-08-20 | 2007-08-14 | Irm Llc | Inhibitors of cathepsin S |
TW200536830A (en) * | 2004-02-06 | 2005-11-16 | Chugai Pharmaceutical Co Ltd | 1-(2H)-isoquinolone derivative |
WO2005075432A1 (ja) * | 2004-02-06 | 2005-08-18 | Chugai Seiyaku Kabushiki Kaisha | 1−(2h)−イソキノロン誘導体およびその抗ガン剤としての使用 |
EP1838296B1 (en) * | 2004-10-20 | 2012-08-08 | Resverlogix Corp. | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases |
-
2006
- 2006-02-21 TW TW095105803A patent/TWI389897B/zh not_active IP Right Cessation
- 2006-02-22 WO PCT/JP2006/303180 patent/WO2006090743A1/ja active Application Filing
- 2006-02-22 AR ARP060100635A patent/AR053140A1/es not_active Application Discontinuation
- 2006-02-22 AU AU2006216289A patent/AU2006216289B2/en not_active Ceased
- 2006-02-22 EP EP06714320A patent/EP1854792B1/en not_active Not-in-force
- 2006-02-22 JP JP2007504750A patent/JP5037333B2/ja not_active Expired - Fee Related
- 2006-02-22 CN CN2006800121207A patent/CN101160303B/zh not_active Expired - Fee Related
- 2006-02-22 US US11/816,910 patent/US7820693B2/en not_active Expired - Fee Related
- 2006-02-22 CA CA002598330A patent/CA2598330A1/en not_active Abandoned
- 2006-02-22 KR KR1020077021674A patent/KR20070107139A/ko not_active Application Discontinuation
-
2008
- 2008-07-10 HK HK08107586.7A patent/HK1112240A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
TWI389897B (zh) | 2013-03-21 |
EP1854792A4 (en) | 2011-05-11 |
KR20070107139A (ko) | 2007-11-06 |
JP5037333B2 (ja) | 2012-09-26 |
US7820693B2 (en) | 2010-10-26 |
AU2006216289B2 (en) | 2011-08-25 |
CN101160303A (zh) | 2008-04-09 |
AU2006216289A1 (en) | 2006-08-31 |
CN101160303B (zh) | 2011-09-28 |
EP1854792B1 (en) | 2012-12-26 |
TW200640900A (en) | 2006-12-01 |
AR053140A1 (es) | 2007-04-25 |
US20090030195A1 (en) | 2009-01-29 |
WO2006090743A1 (ja) | 2006-08-31 |
JPWO2006090743A1 (ja) | 2008-07-24 |
CA2598330A1 (en) | 2006-08-31 |
EP1854792A1 (en) | 2007-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1112240A1 (en) | 1-(2h)-isoquinolone derivative 1-(2h)- | |
EP1847531A4 (en) | PYRAZOLE DERIVATIVE | |
EP1905769A4 (en) | BENZIMIDAZOLE DERIVATIVE WITH HETEROCYCLE SUBSTITUTION | |
SI1919907T1 (sl) | Heterocikliäśna spojina | |
ZA200709051B (en) | Heterocyclic compound | |
IL190450A0 (en) | Substituted pyrazole compounds | |
HK1139390A1 (en) | Cycloalkylamine substituted isoquinolone derivatives | |
EP1942105A4 (en) | AMINODIHYDROTHIAZINE DERIVATIVE | |
HK1107977A1 (en) | Triazole derivative | |
PL1863803T3 (pl) | Podstawione piperydyny | |
ZA200705718B (en) | Substituted triazole derivatives as oxytocin antagnists | |
HK1123038A1 (en) | Heterocyclic compounds | |
HK1131128A1 (en) | Triazole derivative | |
PL1911769T3 (pl) | Pochodna celulozy | |
EP1847535A4 (en) | 1- (piperidin-4-yl) -1H-indole derivatives | |
ZA200900625B (en) | Substituted 1-(azolin-2-yl)-amino-2-aryl-1-hetaryl-ethane compounds | |
HK1115123A1 (en) | Pyridylmethylsulfone derivative | |
IL180889A0 (en) | Pyrazole derivative | |
ZA200800142B (en) | Heterocyclic compound | |
EP1736474A4 (en) | piperidine | |
ZA200802786B (en) | Substituted pyrazole compounds | |
ZA200711025B (en) | N-dihydroxyalkyl-substituted 2-oxoimidazole derivative | |
ZA200803017B (en) | Heterocyclic compounds | |
IL187533A0 (en) | Novel piperidine derivative | |
GB2431230B (en) | Slim line fire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20160222 |